In a patient with non‑alcoholic steatohepatitis who has renal cysts and a 2 cm adrenal mass, what additional imaging should be performed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Additional Imaging for 2 cm Adrenal Mass in NASH Patient with Renal Cysts

For this 2 cm adrenal incidentaloma, obtain a non-contrast CT of the abdomen to measure Hounsfield units (HU) as the essential first step—if HU ≤10, the lesion is definitively benign and requires no further imaging; if HU >10, proceed to either delayed contrast-enhanced CT (washout study) or chemical shift MRI for further characterization. 1, 2, 3

Initial Imaging Strategy

The non-contrast CT is the cornerstone of adrenal mass evaluation because it provides objective HU measurements that can definitively characterize many lesions without additional testing. 2, 3, 4

If HU ≤10 on Non-Contrast CT:

  • The lesion is a benign lipid-rich adenoma—no further imaging is needed 1, 2, 3, 4
  • This applies to masses <4 cm in size 2
  • The patient can proceed directly to hormonal evaluation without additional imaging 3

If HU >10 on Non-Contrast CT (Indeterminate):

You have two equally appropriate second-line imaging options:

Option 1: Delayed Contrast-Enhanced CT (Washout Study)

  • Obtain dynamic contrast-enhanced images followed by delayed images at approximately 10-15 minutes 1, 5
  • Calculate relative percentage washout: [1 - (delayed HU / dynamic HU)] × 100% 5
  • Benign adenomas demonstrate >50% relative washout; malignant lesions show <50% washout 5
  • This approach has 98% accuracy for characterizing adrenal masses 5

Option 2: Chemical Shift MRI

  • Particularly useful if the lesion was discovered on contrast-enhanced CT and you need characterization 1, 2
  • Signal loss on out-of-phase imaging compared to in-phase imaging indicates benign adenoma 1, 4
  • MRI may have better sensitivity and specificity than non-enhanced CT alone, correctly characterizing 89% of lesions with HU between 10-30 1
  • Preferred if radiation exposure is a concern 2

Critical Hormonal Evaluation (Parallel to Imaging)

All adrenal incidentalomas require hormonal screening regardless of imaging appearance, as approximately 5% have subclinical hormone production. 3, 6

Mandatory Screening Tests:

  • Plasma or 24-hour urinary metanephrines to exclude pheochromocytoma—this is non-negotiable before any contrast-enhanced imaging or biopsy 3, 6
  • 1 mg overnight dexamethasone suppression test to screen for autonomous cortisol secretion 6
  • Aldosterone-to-renin ratio only if hypertension or hypokalemia is present 3, 6

Size-Based Risk Stratification

For this 2 cm lesion specifically:

  • Most masses <3 cm are benign (extensive workup not justified in patients without cancer history) 1, 3
  • However, characterization is still warranted given the indeterminate nature at discovery 1
  • Masses >5 cm should be surgically removed due to higher malignancy risk 1, 3

What NOT to Do: Critical Pitfalls

Never Perform Adrenal Biopsy Routinely:

  • Biopsy is rarely indicated and carries unnecessary risks including tumor seeding and potential hypertensive crisis if unsuspected pheochromocytoma is present 1, 3
  • Biopsy should only be considered if non-invasive imaging remains indeterminate AND there is a history of extra-adrenal malignancy 1
  • Always exclude pheochromocytoma biochemically before any biopsy 1

Avoid Premature Advanced Imaging:

  • Do not order FDG-PET for initial characterization—it is reserved for lesions that remain indeterminate after CT and MRI 1
  • Plain radiography and ultrasound have very limited roles and should not be used 1

Do Not Skip Hormonal Evaluation:

  • Skipping hormonal screening can lead to undiagnosed pheochromocytoma, which can cause life-threatening hypertensive crisis during any procedure 6
  • Even radiologically benign-appearing lesions require one-time hormonal evaluation 6

Special Consideration: Renal Cysts

The presence of renal cysts in this patient does not change the adrenal imaging approach. 7 However, be aware that:

  • Adrenal cysts (if this lesion proves to be cystic) are rare (1-2% of incidentalomas) and usually benign 7
  • Cystic adrenal lesions should show low attenuation (<20 HU) on CT and characteristic fluid signal on MRI 7
  • The 2 cm size makes a simple cyst less likely; solid masses require the standard characterization protocol outlined above 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

MRI for Adrenal Nodules: When to Order

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach for Incidental Adrenal Mass

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Cross-sectional imaging work-up of adrenal masses.

World journal of radiology, 2013

Guideline

Preoperative Evaluation of Adrenal Nodules Before Non-Adrenal Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adrenal cysts: an emerging condition.

Nature reviews. Endocrinology, 2023

Related Questions

What is the treatment for adrenal cyst pain?
Does an elderly female with a normal hormone profile and an incidental adrenal mass require a computed tomography (CT) scan for further evaluation?
What is the management plan for a patient with abdominal pain, a 1.5 cm left adrenal adenoma, a simple-appearing right renal cyst, renal (kidney) vascular calcifications, and possible small nonobstructing kidney stones found on a computed tomography (CT) scan of the abdomen?
Is a CT (Computed Tomography) scan with contrast (CT with) enough for the evaluation of an adrenal incidentaloma, or is a CT scan with and without contrast (CT w/wo) recommended?
What is the next step in managing a lesion with indeterminate CT scan results, showing Hounsfield units (HU) of 34, 90, and 60 on the 3 phases, and absolute and relative washout values of 60% and 40%, respectively?
What is urticaria, including its classification, pathophysiology, diagnostic work‑up, and recommended management?
For an adult with episodic Raynaud’s phenomenon (cold‑ or stress‑induced color changes of the fingers or toes), how should nifedipine be initiated, what dosing and titration schedule is recommended, and what monitoring and contraindications are required?
How should a lactating woman with sore throat be evaluated and treated, including safe analgesics and breastfeeding‑compatible antibiotics?
Can high-dose vitamin B12 (cobalamin) cause toxicity or adverse effects in adults, including the elderly or patients with chronic disease?
Is Chloraseptic spray (phenol/benzocaine) safe for a breastfeeding mother to use?
A patient on warfarin 5 mg with a sub‑therapeutic INR of 1.1 (PT 11.8 seconds) is about to start amoxicillin; how should we manage the anticoagulation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.